je.st
news
Tag: lung
Mercks KEYTRUDA (pembrolizumab) Shows Superior Overall Survival Compared to Chemotherapy in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer Whose Tumors Express PD-L1
2015-10-26 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Merck Plans Regulatory Submissions in the U.S. in late 2015 and in the European Union in Early 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced topline results from the KEYNOTE-010 study of KEYTRUDA (pembrolizumab) in advanced non-small-cell lung cancer (NSCLC) demonstrating that the trial met its primary objective. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
shows
express
cell
Rice University study of lung cells suggests anthropogenic carbon nanotubes are common pollutants
2015-10-21 12:55:31| Green Car Congress
Tags: study
university
common
cells
FDA expands lung cancer approval for Bristol-Myers' drug
2015-10-10 01:17:07| Biotech - Topix.net
The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co's immunotherapy drug Opdivo for patients with an additional form of advanced lung cancer. The agency said Opdivo may now be used in patients with non-squamous non-small cell lung cancer whose disease has progressed during or after platinum-based chemotherapy.
Tags: drug
approval
cancer
lung
FDA Expands Approval Of Merck's Keytruda To Lung Cancer
2015-10-04 19:17:21| Biotech - Topix.net
The U.S. Food and Drug Administration on Friday approved Merck & Co Inc's immunotherapy, Keytruda, for patients with the most common form of lung cancer whose tumors produce a specific biological marker. The FDA approval for Keytruda in advanced non-small cell lung cancer is for patients whose tumors express PD-L1, a protein targeted by the drug, and includes a companion diagnostic, made by a unit of Agilent Technologies Inc, to measure those protein levels.
Tags: approval
cancer
lung
expands
Merck wins approval to use drug called Keytruda to treat some forms of lung cancer
2015-10-03 01:23:17| Biotech - Topix.net
Merck & Co. won approval in the U.S. to expand the use of its drug Keytruda to treat a form of advanced lung cancer, though only in patients whose tumors have a biological marker signaling the medicine may work.
Tags: called
forms
drug
approval
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] next »